SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction in the Ludwigshafen risk and cardiovascular health study

被引：0
|
作者：
Grammer, TB
Renner, W
Hoffmann, MM
Winkelmann, BR
Boehm, BO
März, W
机构：
[1] Graz Univ, Clin Inst Med & Chem Lab Diagnost, Graz, Austria
[2] Dept Med, Div Clin Chem, Freiburg, Germany
[3] Univ Heidelberg, Cooperat Unit Pharmacogenom & Appl Genom, Heidelberg, Germany
[4] Dept Med, Div Endocrinol & Diabet, Ulm, Germany
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2005年 / 6卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(05)80013-3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [1] SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
    Grammer, Tanja B.
    Renner, Wilfried
    Hoffmann, Michael M.
    Kleber, Markus
    Winkelhofer-Roob, Brigitte M.
    Boehm, Bernhard O.
    Maerz, Winfried
    FREE RADICAL RESEARCH, 2009, 43 (07) : 677 - 684
  • [2] C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
    Nauck, M
    Winkelmann, BR
    Hoffmann, MM
    Böhm, BO
    Wieland, H
    März, W
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (11): : 1249 - +
  • [3] Alanine to serine polymorphism at position 986 of the calcium sensing receptor associated with coronary heart disease and myocardial infarction.: (The Ludwigshafen Risk and Cardiovascular Health Atudy)
    März, W
    Hoffmann, M
    Renner, W
    Boehm, B
    Winkelman, B
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 87 - 87
  • [4] Hemoglobin, iron metabolism and angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study)
    Grammer, Tanja B.
    Kleber, Marcus E.
    Silbernagel, Guether
    Pilz, Stefan
    Scharnagl, Hubert
    Tomaschitz, Andreas
    Koenig, Wolfgang
    Maerz, Winfried
    ATHEROSCLEROSIS, 2014, 236 (02) : 292 - 300
  • [5] DELTAF508 heterozygosity in cystic fibrosis associated with coronary artery disease in the ludwigshafen risk and cardiovascular health study
    Grammer, TB
    Renner, W
    Winkelmann, BR
    Boehm, BO
    Mätz, W
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 13 - 13
  • [6] ANEMIA AND IRON DEPLETION INDEPENDENTLY ASSOCIATED WITH ANGIOGRAPHIC CORONARY ARTERY DISEASE. (THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH STUDY)
    Grammer, T.
    Silbernagel, G.
    Pilz, S.
    Kleber, M.
    Tomaschitz, A.
    Boehm, B.
    Winkelmann, B.
    Maerz, W.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 108 - 108
  • [7] Cystatin C is independently associated with angiographic coronary artery disease in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Nauck, MS
    März, W
    Nagel, D
    Boehm, BO
    Winkelmann, BR
    CLINICAL CHEMISTRY, 2003, 49 (06) : A55 - A55
  • [8] G(-30)A polymorphism in the promoter of the glucokinase gene associated with angiographic coronary artery disease, type 2 diabetes mellitus and glucose metabolism: The Ludwigshafen Risk and Cardiovascular Health Study (LURIC)
    Nauck, MS
    Winkelmann, BR
    Hoffmann, MM
    Nagel, D
    Nauck, MA
    Boehm, BO
    Maerz, W
    CLINICAL CHEMISTRY, 2003, 49 (06) : A55 - A55
  • [9] Adiponectin serum concentrations in men with coronary artery disease: The LUdwigshafen RIsk and Cardiovascular Health (LURIC) study
    Pilz, S
    Maerz, W
    Weihrauch, G
    Sargsyan, K
    Almer, G
    Nauck, M
    Boehm, BO
    Winkelmann, BR
    Mangge, H
    CLINICA CHIMICA ACTA, 2006, 364 (1-2) : 251 - 255
  • [10] Serum gamma-glutamyltransferase and cardiovascular mortality in subjects with coronary artery disease - The Ludwigshafen risk and cardiovascular health study
    Stojakovic, T.
    Scharnagl, H.
    Wellnitz, B.
    Seelhorst, U.
    Winkelmann, B. R.
    Boehm, B. O.
    Maerz, W.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 148 - 148
12345